@article{f0845eb563a14af483e4ebf55308ef30,
title = "Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses",
keywords = "SARS-CoV-2, COVID-19, viral pandemic, pandemic preparedness, antiviral drugs, drug synergy, model-driven approach, prophylaxis, early treatment, category A-C pathogens, Ebola virus, countermeasures, RESPONSE CURVE SLOPE, HCV GENOTYPE 2, EBOLA-VIRUS, NEUTRALIZING ANTIBODY, CONFORMATIONAL-CHANGE, BROAD-SPECTRUM, SARS-COV-2, INFLUENZA, EFFICACY, FUSION, 11832 Microbiology and virology",
author = "White, {Judith M.} and Schiffer, {Joshua T.} and Ignacio, {Rachel A. Bender} and Shuang Xu and Denis Kainov and Aleksandr Ianevski and Tero Aittokallio and Matthew Frieman and Olinger, {Gene G.} and Polyak, {Stephen J.}",
year = "2021",
doi = "10.1128/mbio.03347-21",
language = "English",
volume = "12",
journal = "mBio",
issn = "2150-7511",
publisher = "American Society for Microbiology",
number = "6",
}